Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Victorian Clinical Genetics Services, |
RCV004790002 | SCV005399165 | pathogenic | Cockayne syndrome type 2 | 2019-08-28 | criteria provided, single submitter | clinical testing | A homozygous nonsense variant was identified, NM_000124.2(ERCC6):c.1914del in exon 9 of 21 of the ERCC6 gene. This nonsense variant is predicted to create a change of tyrosine to a stop at amino acid position 638 of the protein, NP_000115.1(ERCC6):p.(Tyr638*), resulting in the loss of normal protein function through nonsense-mediated decay (NMD). The variant is not present in the gnomAD population database. It has not been previously reported in clinical cases. Other variants predicted to cause NMD have been reported as pathogenic in individuals with this condition (ClinVar). Based on information available at the time of curation, this variant has been classified as PATHOGENIC. |